3 completed, 3 recruiting, 3 unknown, 2 withdrawn. 4 Phase 3, 3 Not applicable, 3 Phase 4, 2 Phase 1, 2 Phase 2.
Follow Aspirin Tablet: new trials by email Literature Review of Aspirin Tablet trials Research Report on Aspirin Tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#), Aspirin Tablet - Cerebral Infarction | Phase 1 | Suspended | Sclnow Biotechnology Co., Ltd. | 40 | 2026-12-31 | 2026-04-23 |
| Comparison of Aspirin Alone Versus Low-Dose Rivaroxaban Plus Aspirin in Chronic Limb-Threatening Ischemia Aspirin tablet, Low-Dose Rivaroxaban Plus Aspirin, - Limb Ischemia | Early Phase 1 | Recruiting | King Edward Medical University | 78 | 2026-06-01 | 2026-09-22 |
| Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes Aspirin tablet, Semaglutide, Sotagliflozin - Cardiovascular Diseases, Heart Failure | Phase 3 | Recruiting | Steno Diabetes Center Copenhagen | 2000 | 2024-07-01 | 2025-01-10 |
| Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP) Statin, Aspirin tablet, Nexlizet - Coronary Artery Disease, Atherosclerosis | Phase 4 | Withdrawn | University of Louisville | 2024-03-01 | 2025-03-17 | |
| Efficacy and Safety of Tirofiban for Patients With BAD (BRANT) Tirofiban, Aspirin tablet, Clopidogrel tablet - Branch Atheromatous Disease | Phase 3 | Completed | Peking Union Medical College Hospital | 516 | 2023-11-09 | 2026-04-15 |
| To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome Rivaroxaban 2.5 Mg Oral Tablet, Clopidogrel tablet, Aspirin tablet - Acute Coronary Syndrome | Phase 4 | Unknown | Sarmad Zahoor | 90 | 2022-10-01 | 2022-10-10 |
| Aspirin for Prophylaxis of TTP Aspirin tablet, Placebo - Thrombotic Thrombocytopenic Purpura | Phase 2 / Phase 3 | Not yet recruiting | The First Affiliated Hospital of Soochow University | 100 | 2022-10-01 | 2022-10-05 |
| Molecular Effects of Aspirin & Metformin on Colonic Epithelium Aspirin tablet, Metformin, Aspirin and Metformin - Colorectal Cancer, Colorectal Neoplasms | Not applicable | Withdrawn | University of Edinburgh | 2022-08-01 | 2025-02-06 | |
| Comparative Study Between Vaginal Progesterone Alone or Combined With Aspirin in Prevention of Recurrent Preterm Birth Aspirin tablet, Placebo - Preterm Birth | Phase 4 | Completed | Menoufia University | 256 | 2022-04-01 | 2024-01-16 |
| A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects LT3001 drug product, Placebo, Aspirin - Acute Ischemic Stroke | Phase 1 | Completed | Lumosa Therapeutics Co., Ltd. | 65 | 2021-03-21 | 2026-03-02 |
| Aspirin Discontinuation After Left Atrial Appendage Occlusion in Atrial Fibrillation Aspirin Tablet, Placebo - Atrial Fibrillation, Stroke | Not applicable | Unknown | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 1120 | 2020-06-01 | 2021-10-12 |
| Postpartum Low-Dose Aspirin and Preeclampsia Aspirin tablet, Placebo oral capsule - Preeclampsia Postpartum | Phase 2 | Recruiting | Columbia University | 100 | 2019-07-22 | 2026-01-22 |
| AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke Apixaban, Aspirin - Stroke | Phase 3 | Terminated | Columbia University | 1015 | 2018-01-19 | 2025-04-09 |
| Mechanism of Drug-drug Interaction Between Salvianolate Injection and Aspirin salvianolate injection, Aspirin Tablet - Angina, Stable | Not applicable | Unknown | Xiyuan Hospital of China Academy of Chinese Medical Sciences | 18 | 2017-10-10 | 2017-10-11 |
Stroke (3) · Ischemic Stroke (2) · Acute Coronary Syndrome (1) · Angina, Stable (1) · Atherosclerosis (1) · Atrial Fibrillation (1) · Cardiovascular Diseases (1) · Cerebral Infarction (1) · Colorectal Neoplasms (1) · Coronary Artery Disease (1) · Diabetes Mellitus, Type 1 (1) · Heart Failure (1) · Hemorrhage (1) · Myocardial Infarction (1) · Premature Birth (1)
Columbia University (2) · King Edward Medical University (1) · Lumosa Therapeutics Co., Ltd. (1) · Menoufia University (1) · Peking Union Medical College Hospital (1) · Sarmad Zahoor (1) · Sclnow Biotechnology Co., Ltd. (1) · Steno Diabetes Center Copenhagen (1) · The First Affiliated Hospital of Soochow University (1) · University of Edinburgh (1) · University of Louisville (1) · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1) · Xiyuan Hospital of China Academy of Chinese Medical Sciences (1)
United States (4) · China (3) · Canada (1) · Denmark (1) · Egypt (1) · Pakistan (1)
Aleha Aziz, MD, MPH (1) · Dinesh Kalra, MD (1) · Farhat VN Din, FRCSed (1) · Jun Ni, MD (1) · Lei Guo, Dr. (1) · Mimi Yeh, PhD (1) · Peter Rossing, MD, DMSc, Proffessor (1) · Randolph S Marshall, MD (1) · Yi-Gang Li, Dr. (1)
PMID 12968085, PMID 23583249, PMID 24998121, PMID 25399274, PMID 26467851, PMID 26822918, PMID 27628431, PMID 28577840, PMID 29103847, PMID 30095350, PMID 30146931, PMID 30158069, PMID 30217228, PMID 30221597, PMID 30355001, PMID 33401223, PMID 33722871, PMID 38324415, PMID 38858147, PMID 39078403, PMID 39133474, PMID 39481070, PMID 39869342, PMID 40265582, PMID 40294164, PMID 40847528, PMID 41720625, PMID 42008258
U01NS095869 (1)